Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
C Philpott1, K Kumaresan1, A W Fjaeldstad2
1James Paget University Hospital, Great Yarmouth, United Kingdom.
Rhinology
|May 27, 2023
Summary
Developing a standardized Core Outcome Set (COS) for olfactory dysfunction (OD) management is crucial. This set ensures consistent outcome measurement in clinical trials, improving research reliability for olfactory dysfunction treatments.
Area of Science:
- Olfactory research
- Clinical trial methodology
- Patient-centered outcomes
Background:
- Evaluating olfactory dysfunction (OD) treatments is hindered by inconsistent outcome reporting in clinical trials.
- A Core Outcome Set (COS) standardizes outcome measurement, facilitating meta-analyses and systematic reviews for OD interventions.
Approach:
- A comprehensive list of potential outcomes was compiled from literature reviews, stakeholder analyses, and existing Patient-Reported Outcome Measures (PROMs).
- An iterative e-Delphi process engaged patients and healthcare practitioners to prioritize outcomes based on importance.
Key Points:
- The developed COS includes subjective assessments (visual analogue scales), quality of life metrics, and psychophysical testing for smell and taste.
- It also incorporates evaluation of side effects, investigational treatments, and patient symptom logs.
Conclusions:
- Implementing this COS in future trials will enhance the value and comparability of research on OD interventions.
- Further work is needed to refine and validate the selected outcome measures for olfactory dysfunction research.
Related Concept Videos
Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Olfaction
44.5K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
44.5K
Physiology of Smell and Olfactory Pathway
8.8K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
The olfactory...
8.8K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K


